- Home
- AEVA vs CERS Comparison
AEVA vs CERS Comparison
Compare AEVA & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEVA
- CERS
- Stock Information
- Founded
- AEVA 2019
- CERS 1991
- Country
- AEVA United States
- CERS United States
- Employees
- AEVA N/A
- CERS N/A
- Industry
- AEVA Auto Parts:O.E.M.
- CERS EDP Services
- Sector
- AEVA Consumer Discretionary
- CERS Technology
- Exchange
- AEVA Nasdaq
- CERS Nasdaq
- Market Cap
- AEVA 241.9M
- CERS 286.0M
- IPO Year
- AEVA N/A
- CERS 1997
- Fundamental
- Price
- AEVA $4.35
- CERS $1.84
- Analyst Decision
- AEVA Buy
- CERS Buy
- Analyst Count
- AEVA 5
- CERS 3
- Target Price
- AEVA $10.53
- CERS $3.17
- AVG Volume (30 Days)
- AEVA 500.9K
- CERS 1.4M
- Earning Date
- AEVA 03-04-2025
- CERS 03-04-2025
- Dividend Yield
- AEVA N/A
- CERS N/A
- EPS Growth
- AEVA N/A
- CERS N/A
- EPS
- AEVA N/A
- CERS N/A
- Revenue
- AEVA $7,980,000.00
- CERS $176,229,000.00
- Revenue This Year
- AEVA $109.02
- CERS $21.42
- Revenue Next Year
- AEVA $63.91
- CERS $11.12
- P/E Ratio
- AEVA N/A
- CERS N/A
- Revenue Growth
- AEVA 176.22
- CERS 14.71
- 52 Week Low
- AEVA $2.20
- CERS $1.38
- 52 Week High
- AEVA $7.25
- CERS $2.59
- Technical
- Relative Strength Index (RSI)
- AEVA 49.42
- CERS 57.20
- Support Level
- AEVA $4.27
- CERS $1.74
- Resistance Level
- AEVA $4.61
- CERS $1.87
- Average True Range (ATR)
- AEVA 0.36
- CERS 0.10
- MACD
- AEVA -0.04
- CERS 0.03
- Stochastic Oscillator
- AEVA 26.19
- CERS 79.49
About AEVA Aeva Technologies Inc.
Aeva Technologies Inc through its Frequency Modulated Continuous Wave (FMCW) sensing technology, designs a 4D LiDAR-on-chip that, along with its proprietary software applications, has the potential to enable the adoption of LiDAR across broad applications from automated driving to consumer electronics, consumer health, industrial automation, and security application. The company operates in North America, EMEA, and Asia. The company derives the majority of its revenue from North America.
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.